PT Mitra Keluarga Karyasehat (MIKA) Q3 2026 earnings summary

Executive summary

• 9M26 revenue rose 7.2% YoY to Rp4,267,467,844,756 and net profit increased 6.9% to Rp1,156,418,007,459.

• Private revenue reached 90% of total, covered patients rose to 62%, and high-complexity care continued to expand.

• Cash and cash equivalents were Rp2,517,975,965,939 at Sep. 30, 2026; the presentation cited Rp2.721T net cash and zero debt.

Financial highlights

• Revenue was Rp4,267,467,844,756 vs Rp3,980,506,006,559; gross profit was Rp2,301,027,020,021 vs Rp2,189,506,182,232.

• Operating income increased to Rp1,365,489,713,350 from Rp1,281,650,207,671; operating margin was 32.0% vs 32.2%.

• EBITDA rose 8.2% to Rp1.672T, with margin of 39.2% vs 38.8%; net income margin was 27.1%, down 0.1 percentage points.

• Basic and diluted EPS was Rp78.11 vs Rp73.12; parent-attributable profit was Rp1,084,849,860,154 vs Rp1,016,964,137,179.

• Net operating cash flow was Rp1,360,168,469,826 vs Rp1,333,181,752,509; presentation operating cash flow was Rp1.338T vs Rp1.333T.

Segment performance

• Inpatient revenue was Rp2,866,264,983,494, up 6.3%; outpatient revenue was Rp1,401,202,861,262, up 9.2%, while total patient volume declined 2.1%.

• High-complexity revenue rose 25.2% to Rp1.194T and its revenue mix increased from 24% to 28%; general care revenue was Rp3.073T.

• Non-JKN revenue increased 9.6% to Rp3.85T; JKN revenue declined 10.8% to Rp422B.

• Jakarta and West Java generated Rp3,231,558 million in net revenue; Central and East Java generated Rp1,035,910 million, and other areas Rp24,750 million before eliminations.